Cogent Biosciences (COGT) Change in Account Payables (2017 - 2021)
Historic Change in Account Payables for Cogent Biosciences (COGT) over the last 5 years, with Q4 2021 value amounting to -$866000.0.
- Cogent Biosciences' Change in Account Payables fell 103118.28% to -$866000.0 in Q4 2021 from the same period last year, while for Dec 2021 it was $2.8 million, marking a year-over-year increase of 21223.99%. This contributed to the annual value of -$2.5 million for FY2025, which is 28475.7% down from last year.
- Per Cogent Biosciences' latest filing, its Change in Account Payables stood at -$866000.0 for Q4 2021, which was down 103118.28% from $2.4 million recorded in Q3 2021.
- Over the past 5 years, Cogent Biosciences' Change in Account Payables peaked at $2.4 million during Q3 2021, and registered a low of -$2.6 million during Q1 2020.
- For the 5-year period, Cogent Biosciences' Change in Account Payables averaged around $115000.0, with its median value being $5500.0 (2020).
- Over the last 5 years, Cogent Biosciences' Change in Account Payables had its largest YoY gain of 4182500.0% in 2021, and its largest YoY loss of 103118.28% in 2021.
- Over the past 5 years, Cogent Biosciences' Change in Account Payables (Quarter) stood at -$774000.0 in 2017, then skyrocketed by 192.51% to $716000.0 in 2018, then surged by 121.93% to $1.6 million in 2019, then plummeted by 94.15% to $93000.0 in 2020, then crashed by 1031.18% to -$866000.0 in 2021.
- Its Change in Account Payables stands at -$866000.0 for Q4 2021, versus $2.4 million for Q3 2021 and $1.7 million for Q2 2021.